ID   CPG18
AC   CVCL_B3RU
DR   Wikidata; Q110432742
RX   PubMed=33426406;
RX   PubMed=34864218;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=33426406; DOI=10.1016/j.ncrna.2020.11.006;
RA   Dolskiy A.A., Yarushkin A.A., Grishchenko I.V., Lemskaya N.A.,
RA   Pindyurin A.V., Boldyreva L.V., Pustylnyak V.O., Yudkin D.V.;
RT   "miRNA expression and interaction with the 3'UTR of FMR1 in FRAXopathy
RT   pathogenesis.";
RL   Noncoding RNA Res. 6:1-7(2021).
//
RX   PubMed=34864218; DOI=10.1016/j.scr.2021.102615;
RA   Gridina M.M., Shitik E.M., Lemskaya N.A., Minina J.M.,
RA   Grishchenko I.V., Dolskiy A.A., Shorina A.R., Maksimova Y.V.,
RA   Yudkin D.V.;
RT   "Derivation of iPS cell line (ICGi032-A) from a patient affected with
RT   fragile X syndrome.";
RL   Stem Cell Res. 57:102615-102615(2021).
//